MedTrace Logo

ANalyzing Olfactory Dysfunction Mechanisms In COVID-19

NCT04445597 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-05-30

No results posted yet for this study

Summary

We aim to understand the mechanism of olfactory dysfunction in COVID-19.

Conditions

Interventions

OTHER

Sampling of tissue

In all groups of participants, tissue from the nasal cavity and olfactory system will be surgically removed

Sponsors & Collaborators

  • Max Planck Research Unit for Neurogenetics

    collaborator UNKNOWN

  • AZ Sint-Lucas Brugge

    collaborator OTHER

  • Universitair Ziekenhuis Brussel

    collaborator OTHER

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Laura Van Gerven · UZ/KU Leuven

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-07
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04445597 on ClinicalTrials.gov